• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

e-Therapeutics PLC

+ Add to Watchlist

3AQ:GR

0.319 EUR 0.006 1.92%

As of 02:08:15 ET on 12/23/2014.

Snapshot for e-Therapeutics PLC (3AQ)

Open: 0.319 Day's Range: 0.319 - 0.319 Volume: 0
Previous Close: 0.313 52wk Range: 0.223 - 0.412 1-Yr Rtn: +13.93%

Stock Chart for 3AQ

No chart data available.
  • 3AQ:GR 0.319
  • 1M
  • 1Y
0.313
Interactive 3AQ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3AQ

Current P/E Ratio (ttm) -
Estimated P/E(01/2015) -
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (01/2015) -0.0350
Est. PEG Ratio -
Market Cap (M EUR) 84.32
Shares Outstanding (M) 264.32
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3AQ

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for 3AQ

e-Therapeutics PLC is a systems biology drug discovery company. The Company uses computers to predict the effects of intervention to proteins in a cell.

Malcolm P YoungChief Executive/FounderSteve MedlicottFinance Director
Stephen Self "Steve"Director:DevelopmentSean T NicolsonSecretary
More Company Profile & Key Executives for 3AQ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil